The metabolic syndrome and changing relationship between blood pressure and insulin with age, as observed in Aboriginal and Torres Strait Islander peoples

Diabetic Medicine

Volumn 22, Issue 11, 2005, Pages 1589-1597

  Schutte, A E ^a,b   Shemesh, T ^b,c   Rowley, K ^d   Best, J D ^d   McDermott, R ^e   O'Dea, Kerin ^b,c  

^a NORTH WEST UNIVERSITY   (South Africa)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c CHARLES DARWIN UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Aborigines; Blood pressure; Insulin resistance; Metabolic syndrome; Torres Strait Islanders

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; INSULIN; LIPID;

ABORIGINE; ADULT; AGE; ANTHROPOMETRY; ARTICLE; AUSTRALIA; BLOOD PRESSURE; BODY MASS; CREATININE URINE LEVEL; DIET RESTRICTION; ETHNIC GROUP; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; WAIST CIRCUMFERENCE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AUSTRALIA; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OCEANIC ANCESTRY GROUP; PREVALENCE;

EID: 27844440864     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01747.x     Document Type: Article

References (44)

1. Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, Valles V, Rios-Torres JM, Franco A et al. High prevalence of metabolic syndrome in Mexico. Arch Med Res 2004; 35: 76-81.
2. Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH. The prevalence of the metabolic syndrome among Arab Americans. Diabetes Care 2004; 27: 234-238.
3. Park HS, Oh SW, Cho SI, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Koreans adults. Int J Epidemiol 2004; 33: 328-336.
4. O'Dea K, Rowley KG. Macrovascular disease risk factors and insulin resistance in Aboriginal and Torres Strait Islander people. J Diabetes Complications 2002; 16: 9-16.
5. Rowley KG, O'Dea K. Diabetes in Australian Aboriginal and Torres Strait Islander peoples. PNG Med J 2001; 44: 164-170.
6. Wang Z, Hoy WE. Body mass index and mortality in Aboriginal Australians in the Northern Territory. Aust NZ J Public Health 2002; 26: 305-310.
7. Leonard D, McDermott R, O'Dea K, Rowley KG, Pensio P, Sambo E et al. Obesity, diabetes and associated cardiovascular risk factors among Torres Strait Islander people. Aust NZ J Public Health 2002; 6: 144-149.
8. Donahue RP, Bean JA, Donahue RD, Goldberg RB, Prineas RJ. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study. Arterioscler Thromb Vasc Biol 1997; 17: 2413-2417.
9. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a bi-racial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol 1999; 150: 667-674.
10. Godsland IF, Leyva F, Walton C, Worthington M, Stevenson JC. Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the Heart Disease and Diabetes Risk Indicators in a Screened Cohort study (HDDRISC-1). J Intern Med 1998; 224: 33-41.
11. Hanley AJG, Karter AJ, Festa A, D'Agostino R Jr, Wagenknecht LE, Savage P et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity. Diabetes 2002; 51: 2642-2647.
12. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H. Insulin resistance, hyperinsulinemia, and blood pressure. Hypertension 1997; 30: 1144-1149.
13. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991; 324: 733-739.
14. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc 2004; 288: 2709-2716.
15. Rowley KG, Best JD, McDermott R, Green EA, Piers LS, O'Dea K. Insulin resistance syndrome in Australian Aboriginal people. Clin Exp Pharmacol Physiol 1997; 24: 776-781.
16. O'Dea K, Spargo RM, Nestel PJ. Impact of westernization on carbohydrate and lipid metabolism in Australian Aborigines. Diabetologia 1982; 22: 148-153.
17. Daniel M, Rowley KG, McDermott R, O'Dea K. Diabetes and impaired glucose tolerance in Aboriginal Australians: prevalence and risk. Diabetes Res Clin Pract 2002; 57: 23-33.
18. McLaughlin TL, Reaven GM. Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance. Am J Med 2003; 114: 501-502.
19. The European Group for the study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364-376.
20. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575-581.
21. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization 1999.
22. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002; 106: 3143-3421.
23. McDermott R, Rowley KG, Lee AJ, Knight S, O'Dea K. Increase in prevalence of obesity and diabetes and decrease in plasma cholesterol in a central Australian Aboriginal community. Med J Aust 2000; 172: 480-484.
24. Rowley KG, Gault A, McDermott R, Knight S, McLeay T, O'Dea K. Reduced prevalence of impaired glucose tolerance and no change in prevalence of diabetes despite increasing BMI among Aboriginal people from a group of remote homeland communities. Diabetes Care 2000; 23: 898-904.
25. Rowley KG, Iser DM, Best JD, O'Dea K, Leonard D, McDermott R. Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia 2000;43:1397-1403.
26. Australian Indigenous Health Infonet. Available from: http:// www.healthinfonet.ecu.edu.au/frames.htm (accessed January 2005).
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
28. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modelling. Diabetes Care 2004; 27: 1487-1495.
29. Statsoft Inc. STATISTICA for Windows (computer program manual). Statsoft I editor. Tulsa, OK: Statsoft Inc. 2000.
30. Kleinbaum DG, Kupper LL. Applied Regression Analysis and Other Multivariable Methods. Boston: Duxbury Press 1978.
31. Abbie AA. Studies in Physical Anthropology, Vols I and II. Canberra: Australian Institute of Aboriginal Studies 1975.
32. Haddon AC. Anthropological Expedition to the Torres Straits. Cambridge: Cambridge University Press 1912.
33. O'Dea K. Diabetes in Australian Aborigines: impact of the western diet and lifestyle. J Intern Med 1992; 232: 103-117.
34. Ford ES, Giles WH, Dietz WH. Prevalence of metabolic syndrome among US adults: finding from the Third National Health and Nutrition Examination Survey. J Am Med Assoc 2002; 287: 356-359.
35. Liese AD, Mayer-Davis J, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev 1998; 20: 157-172.
36. Donahue RP, Skyler JS, Sneiderman N, Prineas RJ. Hyperinsulinemia and elevated blood pressure: cause, confounder, or coincidence? Am J Epidemiol 1990; 132: 827-836.
37. Jarrett R. In defence of insulin: a critique of syndrome X. Lancet 1992; 340: 469-471.
38. Mbanya J-C, Wilkinson R, Thomas T, Alberti K, Taylor R. Hypertension and hyperinsulinemia: a relation in diabetes but not in essential hypertension. Lancet 1988; I: 733-734.
39. Heise T, Magnusson K, Heinemann L, Sawicki PT. Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension 1998; 32: 243-248.
40. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and blood glucose infusions on sympathetic nervous system in normal men. Diabetes 1981; 30: 219-225.
41. Stout RW, Bierman EL, Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975; 36: 319-327.
42. Moore RD. Effect of insulin upon ion transport. Biochem Biophys Acta 1983; 737: 1-49.
43. DeFronzo RA. The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 1981; 21: 165-171.
44. Swinburn BA, Ley SJ, Carmichael HE, Plank LD. Body size and composition in Polynesians. Int J Obes Relat Metab Disord 1999; 23: 1178-1183.